Ignite Creation Date:
2025-12-24 @ 3:54 PM
Ignite Modification Date:
2026-01-28 @ 9:08 PM
Study NCT ID:
NCT01572792
Status:
COMPLETED
Last Update Posted:
2017-04-21
First Post:
2012-04-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Obstructive Pulmonary Disease | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | COPD | View |
| None | Chronic Obstructive Pulmonary Disease | View |
| None | Chronic Bronchitis | View |
| None | Emphysema | View |
| None | Airflow Obstruction, Chronic | View |
| None | Chronic Airflow Obstruction | View |
| None | Chronic Obstructive Airway Disease | View |
| None | Chronic Obstructive Lung Disease | View |